As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
We are very excited to launch our new website! Please take a few moments to click around and explore...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...